Egetis Therapeutics AB (publ) (STO: EGTX)

Egetis Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,697	1,001	1,168	2,200	1,867	-
Market Cap Growth	48.15%	-14.34%	-46.92%	17.85%	-	-
Enterprise Value	1,615	2,802	2,776	3,443	2,825	-
Last Close Price	5.80	14.55	16.98	31.99	27.15	-
PE Ratio	-	-4.28	4.83	9.00	22.30	-
PS Ratio	23.00	3.43	4.45	9.70	10.47	-
PB Ratio	4.23	0.43	0.47	0.97	0.91	-
P/FCF Ratio	22.51	10.24	22.12	39.58	19.41	-
P/OCF Ratio	21.02	9.77	21.51	39.22	19.27	-
EV/Sales Ratio	22.81	9.59	10.57	15.18	15.84	-
EV/EBITDA Ratio	19.26	16.53	19.29	26.17	41.98	-
EV/EBIT Ratio	19.38	16.62	19.34	26.41	42.42	-
EV/FCF Ratio	50.52	28.68	52.57	61.93	29.37	-
Debt / Equity Ratio	0.81	0.88	0.76	0.76	0.75	1.52
Debt / EBITDA Ratio	11.61	12.01	13.13	13.08	22.99	27.62
Debt / FCF Ratio	30.46	20.84	35.79	30.96	16.08	34.68
Asset Turnover	0.06	0.06	0.06	0.06	0.06	-
Quick Ratio	1.71	0.65	0.80	2.62	5.24	0.05
Current Ratio	1.71	0.70	0.83	2.75	5.26	0.11
Return on Equity (ROE)	-2.78%	-8.35%	8.68%	9.68%	4.77%	-
Return on Assets (ROA)	2.34%	2.27%	2.01%	2.04%	1.31%	-
Return on Capital (ROIC)	2.48%	2.41%	2.14%	2.14%	1.38%	-
Earnings Yield	-20.74%	-20.05%	17.75%	9.53%	3.85%	-
FCF Yield	4.44%	9.76%	4.52%	2.53%	5.15%	-
Buyback Yield / Dilution	-2.25%	-	-	-	-	-
Total Shareholder Return	-2.25%	-	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.